30 September 2023 in OphthaTherapy. Therapies in Ophthalmology
Zwyrodnienia rogówki powodują zmianę jej kształtu i utratę przezierności. Podział zwyrodnień rogówki jest dokonywany na podstawie rodzaju substancji odkładających się w jej warstwach. Do substancji powodujących keratopatię można zaliczyć: żelazo, kolagen, hemosyderyny oraz sole wapnia, przez które powstaje keratopatia taśmowata. Ta ostatnia charakteryzuje się odkładaniem zmętnień w powierzchownych warstwach rogówki. W pracy omówiono leczenie keratopatii taśmowatej metodami chelatacji kwasem etylenodiaminotetraoctowym i fototerapeutycznej keratektomii laserem ekscymerowym.
20 December 2021 in OphthaTherapy. Therapies in Ophthalmology
The most common eye disease associated with SARS-CoV-2 infection is conjunctivitis. COVID-19 also predisposes to other manifestations and complications in the organ of vision, often very unusual or not suspected of viral etiology. Since patients infected with SARS-CoV-2 have a higher risk of thromboembolic complications, they may experience such far-reaching consequences as, for example, occlusion of a vein or central retinal artery. The paper presents cases of SARS-CoV-2 infection with ophthalmic symptoms.
31 December 2023 in OphthaTherapy. Therapies in Ophthalmology
Ophthalmic non-steroidal anti-inflammatory drugs are non-steroidal anti-inflammatory drugs used to treat or prevent eye inflammation. Their main action is to relieve symptoms such as pain, redness and swelling that can be caused by eye diseases, injuries or eye surgery. Non-steroidal anti-inflammatory drugs used in ophthalmology include substances such as diclofenac, ketorolac, bromfenac and nepafenac. So far, many studies have been published comparing the effectiveness of various systemic and local non-steroidal anti-inflammatory drugs. This work contains a comparative analysis of the above-mentioned substances in terms of their use and effectiveness in ophthalmology.
30 August 2024 in Chirurgia Narządów Ruchu i Ortopedia Polska
Various methods for treating long bone fractures present promising therapeutic possibilities. In the case presented, particular emphasis was placed on the significant effectiveness of local antibiotic administration combined with bone autografts. The complexity of the injury in 23-year-old patient with multifragmentation of the femur, compounded by infection, necessitated a multistage treatment approach.
31 March 2023 in OphthaTherapy. Therapies in Ophthalmology
Submacular hemorrhage treatment is still an important issue in ophthalmology. At present we lack algorithms of treatment that could be used in clinical practice. Efficacy of every treatment method seems to differ by individual factors simultaneously existing in each patient. Therefore, anti-VEGF agents remain crucial in treating patients with coexisting vasculopathy, while in posttraumatic hemorrhage we should lean towards other approaches, like pneumatic displacement. Operative methods, despite being more invasive and burdened with higher potential risk, are indispensable in large hemorrhages, significantly speeding up clot removal. The primary aim of this work is to collect recent data regarding this issue and to determine usefulness of treatment methods in specific cases, regarding factors such as hemorrhage pathophysiology. The following article pertains to currently used treatment methods, such as: pneumatic displacement, anti-VEGF therapy, rtPA and operative methods.
27 December 2023 in OphthaTherapy. Therapies in Ophthalmology
Keratitis and subsequent damage to the cornea resulting from infectious causes is one of the most serious problems facing ophthalmology today. One of the most common etiologies is fungal infection. Symptoms range from pain and visual deterioration, Wessely ring, inflammatory reaction in the anterior chamber or ropost. Diagnosis in addition to the classic medical and ophthalmologic examination consists of microscopic examination of scrapings, Gram examination combined with culture gives a 90% chance of detecting a fungal etiology. Good results are also observed with PCR testing, which helps speed up diagnosis. Treatment is time-consuming and has a high risk of complications. Two techniques are used to treat fungal infections of the cornea, surgical and pharmacological, such as the antifungal polyene antibiotics nystatin, natamycin, amphotericin B or thiazole derivatives like fluconazole and voriconazole. For filamentous fungi, natamycin 5% or voriconazole 1% are used at various intervals. Natamycin, despite the much poorer availability of the drug in countries such as Africa, has much better clinical results along with a lower risk of complications, as confirmed by the MUTT. A big problem also is subsequent bacterial superinfection, leading to the need for topical antibiotics. Surgical treatment is used in case of failure of pharmacotherapy, up to 4 weeks after the diagnosis of the disease, but it carries a high risk of complications. In the early stages of the disease, a new cross-linking technique can be considered, which is described as an alternative to direct antifungal or antibacterial treatment.